Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Exercise and Genes in Obese (EGO) (EGO)

22 september 2021 uppdaterad av: Jarle Berge

The Effect of Exercise and Genes on Energy Expenditure, Appetite and Quality of Life in Morbidly Obese Patients

Regular exercise has several positive health effects including increased physical fitness and muscle mass. It is well known that increased muscle mass is associated with increased resting energy expenditure which may facilitate weight loss and maintenance. Previous studies have, however, failed to show any consistent association between the intensity of physical exercise and energy expenditure, or relate the variance in these adaptations to genetic variability. Whether high-intensity exercise (HIE) is associated with improved health related quality of life in severely obese patients remains unknown.

This PhD-project is based on a planned randomised controlled study including 50 or more treatment seeking morbidly obese patients who will be randomised to either a 24 week moderate-intensity exercise (MIE) programme or a 24 week high-intensity exercise (HIE) programme. The investigators main hypothesis is that patients randomised to the HIE-program will achieve higher energy expenditure during rest and physical activity after treatment than those allocated to the MIE-programme. In addition, the investigators hypothesise that the HIE-group will achieve a better health related quality of life than the MIE-group after treatment. The investigators also hypothesize that inter-individual variability in adaptation to the two training regimens may be due to genetic factors. If the investigators hypotheses are confirmed, this project might have beneficial clinical implications for future obesity treatment strategies.

Studieöversikt

Status

Aktiv, inte rekryterande

Betingelser

Intervention / Behandling

Studietyp

Interventionell

Inskrivning (Förväntat)

50

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

  • Förenta staterna
    • North Carolina
      • Durham, North Carolina, Förenta staterna, 27708
        • Duke University School of Medicine
  • Norge
      • Bø, Norge, 3800
        • Telemark University College
      • Kristiansand, Norge, 4630
        • University in Agder
      • Trondheim, Norge, 7491
        • Norges Teknisk-naturvitenskapelig Universitet
      • Tønsberg, Norge, 3103
        • Vestfold Hospital trust
    • Raveien
      • Horten, Raveien, Norge, 3184
        • Vestfold University College

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Barn
  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • Treatment seeking weight stable morbidly obese patients (BMI ≥ 40 kg/m2 or BMI 35 to 39.9 kg/m2 with ≥ 1 co morbidity) attending the outpatient Obesity Center, Vestfold Hospital Trust, will be informed about this RCT .

Exclusion Criteria:

  • Uncompensated heart failure
  • Recent myocardial infarction or stroke (<½ years)
  • Severe arrhythmia or heart failure
  • Unstable angina pectoris
  • Renal failure
  • Pregnancy
  • Severe eating disorders
  • Active substance abuse
  • Being on a diet
  • Taking medication known to affect appetite or metabolism (including thyroxin).

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Grundläggande vetenskap
  • Tilldelning: Randomiserad
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: High intensity training group

HIE will consist of the following:

  1. 10 minute warm up at 70% of maximal heart rate.
  2. 4 minute exercise intervals at 90-95% of maximal heart rate.
  3. 4 minute interval bouts repeated 4 times.
  4. Between each bouts there will be a 3 minute active recovery at 70% of maximal heart rate
  5. After all four bouts are completed; 5 minute cool-down at 70% of maximal heart rate.
Övrig: Training intensity intervention
High intensity training group describes the group performing high intensity exercise intervention. Moderate intensity training group describes the the group performing moderate exercise intervention
Andra namn:
  • EGO-HIT
Experimentell: Moderate intensity training group

MIE will consist of the following:

  1. 10 minute warm up at 50% of maximal heart rate.
  2. 35 minutes exercise at 70% of maximal heart rate.
  3. 4 minute cool-down at 50% of maximal heart rate.
Övrig: Training intensity intervention
High intensity training group describes the group performing high intensity exercise intervention. Moderate intensity training group describes the the group performing moderate exercise intervention
Andra namn:
  • EGO-HIT

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Energy expenditure during physical activity
Tidsram: 0, 8, 12 and 24 weeks
Energy expenditure (EE) during volitional activity will be measured with ergo-spirometry tests one week before the exercise intervention period starts, and repeated after each exercise period. Increasing the aerobic work capacity is supposed to give the same proportional increase in energy expenditure at any given maximal intensity.
0, 8, 12 and 24 weeks

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Resting metabolic rate
Tidsram: 0, 8, 12 and 24 weeks
Resting metabolic rate will be measured with ergo-spirometry test one week before the exercise intervention period starts, and repeated after each exercise period. Increasing the aerobic work capacity is supposed to give increased resting metabolic rate.
0, 8, 12 and 24 weeks
Cardiorespiratory fitness
Tidsram: 0, 8, 12 and 24 weeks
Exercise may have a positive effect on cardiorespiratory fitness and will be measured with ergo-spirometry test
0, 8, 12 and 24 weeks
Body mass index
Tidsram: 0, 8, 12 and 24 weeks
Exercise may have a positive effect on weight change and will be calculated as weight in kilograms divided by height in meters squared
0, 8, 12 and 24 weeks
Waist circumference
Tidsram: 0, 8, 12 and 24 weeks
Exercise may have a positive effect on waist circumference and will be measured midway between the bottom edge of the lower rib and upper iliac crest in the horizontal plane.
0, 8, 12 and 24 weeks
Fat mass and fat free mass
Tidsram: 0, 8, 12 and 24 weeks
Exercise may have a positive effect on body composition and will be measured with the bioelectrical impedance analyser Tanita BC-418
0, 8, 12 and 24 weeks
Appetite control
Tidsram: 0,12 and 24 weeks
Patient self-appraisal of hunger and fullness will be assessed during fasting and after a standardised breakfast every 30 minutes (for a period of 3hours) using visual analogue scales.
0,12 and 24 weeks
Genetic susceptibility
Tidsram: 0, 8, 12 and 24 weeks
We hypothesize that inter-individual variability in adaptation/response to the two training regimens may also be due to genetic factors. We have designed a gene panel consisting of recognized and previously reported risk genes/variants with flanking sequences relevant for exercise (VO2max), participation in physical activity, obesity, diabetes, asthma and obesity related sub-phenotypes. The panel covers 1.2 Mb and includes 299 genes (exons with exon-intron junctions) and 1468 intronic and intergenic SNPs. Next-generation sequencing will be performed using a gene panel of selected genes/genetic regions by Illumina Nextera technology. The method involves enzymatic fragmentation of DNA and probe-based enrichment. The samples will be sequenced (paired-end, 2x100 bp) on a HiScanSQ. All wet lab methods (with other gene panels) are ISO15189 certified and in routine use at Unit for Medical Genetics at Telemark Hospital.
0, 8, 12 and 24 weeks
Short form health survey (RAND-36)
Tidsram: 0,12 and 24 weeks
RAND-36 is a 36-item measure of generic HRQOL consisting of eight additive subscales (Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health) and two summary scores each based on four subscales (Physical Component Summary and Mental Component Summary). Scores on all subscales range from 0 to 100. Summary-scores will be norm-based, with mean (SD) 50 (10). Higher scores on all scales represent better HRQOL.
0,12 and 24 weeks
Impact on Weight Questionnaire (IWQOL-Lite)
Tidsram: 0,12 and 24 weeks
IWQOL-Lite is a 36-item measure of generic HRQOL consisting of eight additive subscales (Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, and Mental Health) and two summary scores each based on four subscales (Physical Component Summary and Mental Component Summary). Scores on all subscales range from 0 to 100. Summary-scores will be norm-based, with mean (SD) 50 (10). Higher scores on all scales represent better HRQOL.
0,12 and 24 weeks
Weight-Related Symptom Measure (WRSM)
Tidsram: 0,12 and 24 weeks
WRSM is a 20-item measure for the presence and distress of 20 weight-related symptoms. The distress scores of the symptoms are reported on a six-point likert scale. Two summary scores are calculated; an additive score of presence of symptoms ranging from 1 to 20 and a symptom distress score for all symptoms. Symptom distress scores range from 0 to 100, with higher scores indicating a higher or worse total symptom distress.
0,12 and 24 weeks
Power of Food scale (PFS)
Tidsram: 0,12 and 24 weeks
PFS assess both the psychological impact and respondent's responsiveness to a food-abundant environment. This is a 15-item scale whose items pertain to three situations: food being readily available in the environment but not physically present, food is physically present, but not tasted, and food is first tasted but not already consumed. The three subscales is scored 0-100 with higher scores indicating greater eating problems.
0,12 and 24 weeks
Binge Eating Scale (BES)
Tidsram: 0,12 and 24 weeks
BES comprise 16 items assessing binge eating problems. Additive scores range between 0-46, with higher scores indicating greater problems. Cut-off scores have been established to determine binge severity, with "severe" represented by scores > 27, "moderate" by scores 18-26, and "mild-none" by scores < 17.
0,12 and 24 weeks
Three Factor Eating Questionnaire (TFEQ -R21)
Tidsram: 0,12 and 24 weeks
TFEQ -R21 is a 21-item questionnaire covering eating behavior domains: the cognitive restraint scale (6 items) assesses control over food intake and influence over body weight and body shape; the emotional eating scale (6 items) measures the propensity to overeat in relation to negative mood states, e.g., when feeling lonely, anxious, or depressed; and, the uncontrolled eating scale (9 items) assesses the tendency to lose control over eating when feeling hungry or when exposed to external stimuli
0,12 and 24 weeks
Body weight change
Tidsram: 0, 8, 12 and 24 weeks
Exercise may have a positive effect on weight change
0, 8, 12 and 24 weeks

Andra resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Substrate oxidation
Tidsram: 0, 8, 12 and 24 weeks
Exercise may have a positive effect on substrate oxidation (for example fat oxidation) and will be measured with ergo-spirometry tests
0, 8, 12 and 24 weeks
Hip circumference
Tidsram: 0, 8, 12 and 24 weeks
Exercise may have a positive effect on hip circumference and will be measured on the widest part of the hip in the horizontal plane.
0, 8, 12 and 24 weeks
Daily activity
Tidsram: 0, 17 and 24 weeks
Exercise can affect daily activity. Measurements of 24-hour activity during free living will be performed with accelerometer (ActiGraph wGT3x-BT, Pensacola, FL, USA). The 24-hour activity expressed as daily activity counts per minute (Vector magnitude, CPM). The registrations will last for 24 hours during 7 days including the weekend.
0, 17 and 24 weeks
Total energy intake
Tidsram: 0 and 24 weeks
Exercise can affect total energy intake. A 180 items food frequency questionnaire developed in Norway and validated to assess habitual diet among men and women, was will be used. The dietary data will be entered by scanning, using the teleform program (10.0) (Datascan, Oslo, Norway). Daily intake of foods, energy and nutrients will be calculated using software (KBS version 7.3 2017; developed at the institute of Basic Medical Sciences, University of Oslo). The software is based on Norwegian food composition table (Norwegian Food Composition Database 2017. Norwegian Food Safety Authority)
0 and 24 weeks

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Sponsor

Jarle Berge

Samarbetspartners

Norwegian University of Science and Technology
Duke University
University of Agder
University of South-Eastern Norway
Vestfold University College

Utredare

  • Studierektor: Jøran Hjelmesæth, professor, The Hospital of Vestfold

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

1 januari 2015

Primärt slutförande (Förväntat)

1 augusti 2023

Avslutad studie (Förväntat)

1 augusti 2023

Studieregistreringsdatum

Först inskickad

26 juni 2014

Först inskickad som uppfyllde QC-kriterierna

5 december 2014

Första postat (Uppskatta)

8 december 2014

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

23 september 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

22 september 2021

Senast verifierad

1 september 2021

Mer information

Termer relaterade till denna studie

Nyckelord

Andra studie-ID-nummer

  • EGO

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Fetma

Kliniska prövningar på Training intensity intervention

Sök liknande försök

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

CROs by country

CROs in Tunisia

Betingelser

Sällsynta sjukdomar

Läkemedelsinterventioner

Kosttillskott

Sponsor / medarbetare

Platser

3
Prenumerera